logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
IRON
Disc Medicine, Inc.
74.95
2 x 53.15
2 x 93.59
bid
ask
+
1.81
2.47%
2 @ 04:06 AM
73.80 -1.15 (1.53%)
Ytd-5.62%
1y46.59%
72.50
day range
75.41
40.00
52 week range
99.50
Open72.91Prev Close73.14Low72.50High75.41Mkt Cap2.86B
Vol960.50KAvg Vol534.06KEPS-6.64P/EN/AForward P/E-9.88
Beta2.10Short Ratio13.57Inst. Own113.78%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg69.02200-d Avg73.631yr Est101.55

IRON News

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities

New York, New York--(Newsfile Corp. - June 30, 2026) - WHY: Rosen Law Firm, a global investor rights

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
prnewswire.com
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Inv

NEW YORK, June 29, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, cont

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You

NEW YORK, June 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securitie

New York, New York--(Newsfile Corp. - June 27, 2026) - WHY: Rosen Law Firm, a global investor rights

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday&

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

benzinga.com
Morgan Stanley Maintains Overweight on Disc Medicine, Raises Price Target to $85

Morgan Stanley analyst Sean Laaman maintains Disc Medicine (NASDAQ:IRON) with a Overweight and ra
benzinga.com
Wedbush Reiterates Outperform on Disc Medicine, Maintains $88 Price Target

Wedbush analyst David Nierengarten reiterates Disc Medicine (NASDAQ:IRON) with a Outperform and m
benzinga.com
Disc Medicine Completes FDA Type A Meeting Regarding The Complete Response Letter To The New Drug Ap

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discove
benzinga.com
Disc Medicine Presents Updated Data From Myelofibrosis And Anemia Treatment RALLY-MF Phase 2 Trial S

Consistent, substantial decreases in hepcidin reaching >75% reduction from baseline and correspon